{
    "Title": "Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial",
    "URL": "https://doi.org/10.1371/journal.pntd.0005008",
    "Published": "September 16, 2016",
    "Subject_Areas": [
        "Schistosoma mansoni",
        "Schistosoma haematobium",
        "Malaria",
        "Eggs",
        "Urine",
        "Drug therapy",
        "Adverse events",
        "Children"
    ],
    "Authors": {
        "Beatrice Barda": [
            "Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland",
            "University of Basel, Basel, Switzerland"
        ],
        "Jean T. Coulibaly": [
            "Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland",
            "University of Basel, Basel, Switzerland",
            "Unite´ de Formation et de Recherche Biosciences, Universite´ Felix Houphouët-Boigny, Abidjan, Côte d’Ivoire",
            "Centre Suisse de Recherches Scientifiques en Côte d’Ivoire, Abidjan, Côte d’Ivoire"
        ],
        "Maxim Puchkov": [
            "Department of Pharmaceutical Technology, University of Basel, Basel, Switzerland"
        ],
        "Jörg Huwyler": [
            "Department of Pharmaceutical Technology, University of Basel, Basel, Switzerland"
        ],
        "Jan Hattendorf": [
            "Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland"
        ],
        "Jennifer Keiser": [
            "Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland",
            "University of Basel, Basel, Switzerland"
        ]
    }
}